Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
45 participants
OBSERVATIONAL
2004-01-31
2006-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Blind people and sighted volunteers between 18 and 80 years of age who have no psychiatric problems or neurological problems (other than blindness) may be eligible for this study. Candidates are screened with a medical interview and examination.
Participants undergo one or both of the following procedures:
Behavioral experiment
Sighted participants are blindfolded during this experiment. Subjects sit comfortably in front of a table. They are presented with a number of surfaces placed on a table one at a time and are given 10 seconds to feel each surface with the index finger on their dominant hand. They must concentrate and memorize the surfaces as best they can. After a 15-minute break, they are again presented with a series of surfaces and given 10 seconds to feel each one. This time, they must say as quickly as possibly whether the surface is one they touched previously or is a new surface.
Functional MRI
MRI uses a strong magnetic field and radio waves to obtain images of body organs and tissues. In this study, subjects undergo MRI scanning of the brain while performing the same touch test described above. For the MRI, the subject lies on a table that slides into the scanner. The MRI machine detects change in the brain regions involved in performing the task.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Plasticity of Verbal Memory in the Blind
NCT00059189
Brain Activity in Visual-Motor Behavior
NCT00077038
The Connection Between Areas in the Brain of Blind Patients
NCT00001926
GABA Levels in the Brains of Blind People
NCT00357409
Neural Basis of Sensory Learning: Brain Regions
NCT05079516
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
OBJECTIVES:
The first objective of this protocol is to determine if tactile memory is superior in early blind subjects relative to that in late blind and sighted control subjects.
The second objective is to determine if the visual cortex of blind people can participate in higher-order processing of tactile information such as tactile encoding recognition.
STUDY POPULATION:
Our experiments will make use of early blind, late blind, and sighted control subjects.
DESIGN:
Experiment 1: We will quantify the ability of our study populations to encode into and retrieve from episodic tactile memory. Subjects will be presented with a series of surfaces that they are to palpate and commit to memory, after which they will rest for ten to fifteen minutes. The old surfaces will then be presented again with a same number of new surfaces randomly interleaved. Subjects are to discriminate old from new surfaces.
Experiment 2: We will identify cortical areas associated with successful tactile memory encoding and retrieval in blind individuals and sighted controls using functional magnetic resonance imaging (fMRI). Subjects will perform the memory task from Experiment 1 while in the MRI machine.
OUTCOME MEASURES:
Experiment 1: The primary outcome measure will be recognition memory, a corrected measure of the number of old stimuli correctly remembered.
Experiment 2: The primary outcome measure will be the number of voxels significantly activated in primary visual cortex in early blind subjects as compared to late blind subjects and sighted controls.
We expect the magnitude of visual cortex activation in the early blind during a tactile memory task to correlate with superior performance on the task.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Late Blind Subjects: Only compliant late blind subjects who have lost their vision after age 4 years due to diseases affecting the peripheral components of the visual system, i.e., blind subjects without any further neurological problems, and with normal MRI brain scans, will be selected.
Sighted controls: Only compliant adult healthy volunteers between the ages of 18 and 80 years with no history of neurological and psychiatric illness who are able to concentrate and to perform simple attention tasks are eligible.
Blind subjects: Early and late blind subjects (aged 18 to 80) will be included in this protocol.
Sighted subjects: Healthy sighted (normal or corrected-to normal vision) matched in age, sex, and handedness to the early blind subjects.
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Neurological Disorders and Stroke (NINDS)
NIH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Neurological Disorders and Stroke (NINDS)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Amedi A, Malach R, Hendler T, Peled S, Zohary E. Visuo-haptic object-related activation in the ventral visual pathway. Nat Neurosci. 2001 Mar;4(3):324-30. doi: 10.1038/85201.
Amedi A, Raz N, Pianka P, Malach R, Zohary E. Early 'visual' cortex activation correlates with superior verbal memory performance in the blind. Nat Neurosci. 2003 Jul;6(7):758-66. doi: 10.1038/nn1072.
Bailes SM, Lambert RM. Cognitive aspects of haptic form recognition by blind and sighted subjects. Br J Psychol. 1986 Nov;77 ( Pt 4):451-8. doi: 10.1111/j.2044-8295.1986.tb02210.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-N-0110
Identifier Type: -
Identifier Source: secondary_id
040110
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.